ONgoing Telmisartan Alone or in combination with Ramipril Global Endpoint Trial
Latest Information Update: 08 Oct 2023
At a glance
- Drugs Telmisartan (Primary) ; Ramipril
- Indications Angina pectoris; Cardiovascular disorders; Heart failure; Hypertension; Intermittent claudication; Left ventricular hypertrophy; Myocardial infarction; Stroke; Unstable angina pectoris
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Acronyms ONTARGET
- Sponsors Boehringer Ingelheim
- 28 Mar 2019 Results of pooled post hoc analysis from ONTARGET/TRANSCEND studies assessing cardiovascular outcomes and achieved blood pressure published in the European Heart Journal.
- 24 Dec 2018 Results assessing resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals from ONTARGET and TRANSCEND trials, published in the European Heart Journal.
- 01 Feb 2013 Results published in the Journal of Hypertension.